SEMPREXD (Actient Pharmaceuticals, LLC)
Welcome to the PulseAid listing for the SEMPREX drug offered from Actient Pharmaceuticals, LLC. This Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC],Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actient Pharmaceuticals, LLC |
NON-PROPRIETARY NAME: | acrivastine and pseudoephedrine hydrochloride |
SUBSTANCE NAME: | ACRIVASTINE; PSEUDOEPHEDRINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC],Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2012-01-26 |
END MARKETING DATE: | 0000-00-00 |
SEMPREX D HUMAN PRESCRIPTION DRUG Details:
Item Description | SEMPREX D from Actient Pharmaceuticals, LLC |
LABELER NAME: | Actient Pharmaceuticals, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 8; 60(mg/1; mg/1) |
START MARKETING DATE: | 2012-01-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 52244-404_84b92035-190d-4a3b-90de-12fba1c0bb4a |
PRODUCT NDC: | 52244-404 |
APPLICATION NUMBER: | NDA019806 |
Other ACRIVASTINE; PSEUDOEPHEDRINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: